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Background: Shigella species are an important cause of diarrhea in developing countries. These bacteria normally
acquire their antibiotic resistance via several different mobile genetic elements including plasmids, transposons, and
integrons involving gene cassettes. During a diarrhea surveillance study in Thimphu, Bhutan in June and July, 2011,
Shigella sonnei were isolated more frequently than expected. This study describes the antibiotic resistance of these
S. sonnei isolates.
Methods: A total of 29 S. sonnei isolates from Thimphu, Bhutan was characterized for antimicrobial susceptibility by
disc diffusion assay and minimum inhibitory concentration (MIC) assay. All isolates were tested by pulsed-field gel
electrophoresis (PFGE) with restriction enzyme XbaI and were tested for plasmid. The plasmid patterns and the PFGE
patterns were analyzed by Bionumerics software. DNA sequencing was performed on amplified products for gyraseA
gene and class 1 and class 2 integrons. S. sonnei isolates were classified for incompatibility of plasmids by PCR-based
replicon typing (PBRT).
Results: These S. sonnei were resistant to multiple drugs like ciprofloxacin, nalidixic acid, trimethoprim-sulfamethoxazole,
streptomycin, and tetracycline but susceptible to azithromycin. All isolates had class 2 integrons dfrA1, sat1 and aadA1
genes. Two point mutations in Gyrase A subunit at position Ser83Leu and Asp87Gly were detected in these quinolone
resistant isolates. The plasmid and PFGE patterns of S. sonnei isolates suggested a clonal relationship of the isolates.
All isolates carried common ColE plasmid. ColE plasmid co-resided with B/O plasmid (nine isolates) or I1 plasmid
(one isolate).
Conclusions: The characteristics of 29 S. sonnei isolates from Thimphu, Bhutan in June and July, 2011 are identical in
PFGE, plasmid and resistance pattern. This study suggests that these recent S. sonnei isolates are clonally related and
multidrug-resistant.
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Shigella species are an important cause of diarrhea in
developing countries. In 2013, the World Health
Organization (WHO) reported the diarrheal disease is a
leading cause of child mortality and morbidity in the
world, and mostly results from contaminated food
and water sources. Worldwide, 780 million individuals* Correspondence: sirigader@afrims.org
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lack improved sanitation. Diarrhea due to infection is
widespread throughout developing countries. Globally,
there are nearly 1.7 billion cases of diarrheal disease every
year. Each year diarrhea kills around 760, 000 children
under five years of age [1]. Bhutan is a developing country
in the South Asia region with decent health care access
throughout the country. The current population of
the country is around 706,800 with about 80% of the
population residing in rural areas. Children under
5 years of age comprise about 10% of the total populationtd. This is an Open Access article distributed under the terms of the Creative
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diarrheal disease is an important public health problem.
Treatment for diarrheal disease in the country is empirical
rather than evidence based due to the lack of diarrhea
etiology data. In the Annual Health Bulletin, Bhutan
reported an average of 60,000-70,000 cases of diarrhea
and 25,000-30,000 cases of dysentery per year from
2005–2009. The overall incidence of diarrheal diseases
in Bhutan during 2010 was 126.6 per 1,000 people. The
percentage of diarrhea and dysentery that occurred in
children less than 5 years of age for 2009 were 34% and
30%, respectively [3]. Shigellosis has been a notifiable
disease in Bhutan since May 2010 with only one case
reported [4]. In 2011, a reported diarrhea outbreak
probably caused by Shigella flexneri occurred during
March 2011 in a remote village in Mongar District,
Bhutan [5]. During a diarrhea surveillance study in
Thimphu, Bhutan from March 2011 to February 2013,
Shigella sonnei was isolated from children’s stool samples
more frequently than expected in June and July 2011.
The rapid emergence of multidrug-resistant (MDR)
strains is largely due to their ability to acquire and
disseminate exogenous genes associated with mobile
genetic elements such as, transposons, integrons,
plasmids, and genomic islands [6]. Some transposons
code for single resistance [e.g. TEM b-lactamase (Tn3),
kanamycin (Tn5) and tetracycline resistance (Tn10)], but
plasmids and transposons coding multiple drug resistance
often possess another genetic element, the integron
[7]. Integrons are genetic elements that contain the
components of a site-specific recombination system
that recognizes and captures mobile gene cassettes.
Based on the characteristics of their integrase genes,
four classes of integrons (classes 1, 2, 3, and 4) have
been identified to date [8]. Class 1 and 2 integrons have
been frequently reported in studies of human Shigella [9].
Antibiotic-resistance plasmids frequently contain genes
conferring resistance to several different antibiotics.
The ability to recognize and categorize plasmids in
homogeneous groups on the basis of their phylogenetic
relatedness can be helpful to analyze their distribution in
nature, the relationship with the host cell and to discover
their evolutionary origin [10].
To further study the multidrug resistance in Thimphu,
Bhutan, we characterized S. sonnei isolates from children,
the genetic basis of antibiotic resistance including class 1




A diarrhea etiology study was conducted at Jigme Dorji
Wangchuk National Referral Hospital (JDWNRH) in
Thimphu, Bhutan from March 2011 to February 2013.Children 3 months to 5 years of age presenting for clinical
care at JDWNRH with a chief complaint of acute diarrhea
(3 or more loose stools in the previous 24 hours starting
no more than 72 hours before presenting were eligible to
provide a stool sample as cases. Children 3 months to
5 years presenting for clinical care at JDWNRH for other
causes, who not had a history of diarrhea in the past
2 weeks and had not received antibiotics in the past 3 days
were eligible to provide stool samples as controls. The
study was approved by the Research Ethics Board of Health
(REBH), Bhutan and the Institutional Review Board (IRB),
Walter Reed Army Institute of Research (WRAIR). Stool
samples were collected from children with verbal informed
consent from their parent or guardian.
Specimen processing and identification
Stool samples collected in Cary-Blair transport medium
were cultured on MacConkey (MAC) and Hektoen
Enteric (HE) agar (Becton-Dickinson and Company,
Sparks, MD, USA) and subsequently incubated at 37°C
overnight. Plates are examined for the presence of colonies
resemble to Shigella and identified by standard biochemical
tests and further serotyped by agglutination test (Denka
Seiken, Japan) at the Armed Forces Research Institute of
Medical Sciences (AFRIMS) in Bangkok, Thailand [11].
Isolates were stored in Luria-Bertani (LB) broth containing
15% glycerol at −70°C until use.
Antimicrobial susceptibility methods
The S. sonnei isolates were tested for susceptibility to
antimicrobial agents by the standard disk diffusion
method according to Clinical and Laboratory Standards
Institute (CLSI) guideline [12]. Antimicrobial disks
included azithromycin (AZM 15 μg), nalidixic acid
(NA 30 μg), ciprofloxacin (CIP 5 μg), ampicillin (AM 10 μg),
trimethoprim-sulfamethoxazole (SXT 1.25/23.75 μg),
ceftriaxone (CRO 30 μg), streptomycin (S 10 μg), and
tetracycline (TE 30 μg) (Sensi-Disc; Becton Dickinson,
NJ, USA). Minimum inhibitory concentrations (MIC)
for AZM, NA, and CIP were also determined by E-test
(AB Biodisk, Solna, Sweden). The standard disk diffusion
method and MIC were interpreted according to CLSI
guideline [12]. Organisms used for quality control of
antimicrobial susceptibility testing included Escherichia coli
ATCC 25922, Staphylococcus aureus ATCC 25923, and
Staphylococcus aureus ATCC 29213. In the absence of
CLSI definitive standards for azithromycin (AZM)
breakpoints of the family Enterobacteriaceae, inter-
pretive standards as published by the disk manufac-
turer for Staphylococcus spp. was used (BBL package
insert; Becton-Dickinson and Company, Sparks, MD,
USA). Multidrug-resistant (MDR) S. sonnei strains were
defined as strains that were resistant to two or more
antimicrobial agents.
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Pulsed-field gel electrophoresis (PFGE) was performed
according to the One-Day (24–28 h) Standardized
Laboratory Protocol for Molecular Subtyping by PFGE [13]
with minor modifications. The cell density of each isolate
was adjusted by spectrophotometer (Bio-Rad, Hercules,
CA, USA). Plug slices of samples and Salmonella
Braenderup H9812 universal size standard were prepared
for XbaI digestion and loaded on 1% SeaKem Gold
agarose (Lonza, Rockland, ME, USA) with 0.5x TBE
pH 8.3 (890 mM Tris, 890 mM Borate, 20 mM EDTA).
The gel was electrophoresed by CHEF Mapper system
(Bio-Rad, Hercules, CA, USA). The electrophoresis
conditions for XbaI digestion were auto algorithm mode,
30–600 kb for molecular weight range, and 19 h for run
time. The gel images were captured by a gel documentation
system (Syngene, Cambridge, UK). Combined dendrogram
of PFGE and antimicrobial susceptibility were generated by
BioNumerics Software version 6.0 (Applied Maths, Kortrijk,
Belgium), UPGMA (Unweighted Pair Group Method
with Arithmetic Mean) type and Dice coefficient with
1.0% optimization and tolerance.
Plasmid analysis
The S. sonnei isolates, E. coli V.517 and E. coli 39R were
grown in 5 ml LB broth at 200 rpm, 37°C overnight.
Plasmid DNAs were extracted by alkaline lysis method
[14] and separated by electrophoresis on a 0.8% agarose gel
with 0.5x TBE using plasmids from E. coli V.517 and E. coli
39R as reference size markers. A combined dendrogram of
plasmid and antimicrobial susceptibility were generated
by BioNumerics Software version 6.0 (Applied Maths,
Kortrijk, Belgium), UPGMA type and Dice coefficient
with 1.5% optimization and tolerance.
Multiplex PCR for plasmid replicon typing
The S. sonnei isolates were examined by PCR using three
multiplex primer panels for the presence of 18 replicon
plasmids and three singleplex primer pairs for an
additional 3 replicon plasmids, ColE, IncU and IncR
plasmids (Table 1). S. sonnei isolates and reference
plasmids for controls were grown on TSA plates at 37°C
overnight and were extracted for genomic DNA using
DNeasy Blood and Tissue Kit (QIAGEN, Valencia, CA,
USA). The reference plasmid controls were kindly
provided by Dr. Alessandra Carottoli. PCR reactions
were performed as previously described [15,16]. Positive
controls as well as a negative control without DNA were
run with each multiplex primer panel.
Amplification of Integrons, DNA gyrase A gene and
azithromycin resistance gene (mphA)
The S. sonnei isolates were grown on TSA plates at 37°C
overnight and purified for genomic DNA extracted usingDNeasy Blood and Tissue Kit (QIAGEN, Valencia,
CA, USA). DNA templates were kept at −20°C before
use. Extracted DNA was amplified for class 1 and
class 2 integrons, DNA gyrase A gene and azithromycin
resistance gene (mphA) by PCR (Table 1), as previously
described [17-19].
Restriction fragment length polymorphism (RFLP)
RFLP was performed on amplified DNA of class 2 integrons
of the S. sonnei isolates by using Int2CaF and Int2CaR
primers (Table 1) and PCR conditions as previously
described [17]. Amplified product was purified by Wizard®
SV Gel and PCR Clean-Up System (Promega, Madison,
WI, USA) and digested with XbaI (Roche, Indianapolis, IN,
USA) at 37°C for 2 hours. The restriction fragments were
detected on a 1.5% agarose gel by electrophoresis with 0.5X
TBE buffer. Two-log DNA ladder (BioLabs, Ipswich, MA,
USA) was used as a standard DNA marker.
Sequencing and bioinformatics analysis
The amplified PCR products of S. sonnei isolates, class 1
integrons, class 2 integrons and the gyrase A gene were
purified by Wizard® SV Gel and PCR Clean-Up System
and were sequenced (Macrogen, Korea). The nucleotide




During the surveillance study from March 2011 to
February 2013 at JDWNRH in Thimphu, Bhutan, a
total of 1,133 children from 3 months to 5 years of age
were studied. This included 571 children with diarrhea and
562 non-diarrhea controls. The percentage of Shigella spp.
detected were 70.9% (56/79) of S. sonnei, 19.0% (15/79) of
S. flexneri, 8.9% (7/79) of S. boydii and 1.2% (1/79) of S.
dysenteriae. An epidemic curve of the number of cases per
month of S. sonnei from March 2011 to February 2013 was
created, a total of 56 S. sonnei isolates were 51 isolates from
cases and 5 isolates from controls (Figure 1). During the
apparent outbreak of S. sonnei in Thimphu, Bhutan in June
and July 2011, a total of 25 S. sonnei were isolated from
cases and 4 S. sonnei were isolated from asymptomatic
controls. The other 27 S. sonnei isolates were sporadically
found from March 2011 to February 2013. All 29 S. sonnei
isolates during the outbreak period were characterized in
this study. Four S. sonnei from Nepal in 2007–2008 and
five S. sonnei from Thailand in 2008 isolated previously at
AFRIMS were included in this study for comparison.
Multidrug-resistant Shigella sonnei in Bhutan
In this study, the 29 S. sonnei isolates from Thimphu,
Bhutan were resistant to NA, CIP, SXT, S and TE by
disk diffusion assay (Table 2). These 29 isolates had
Table 1 PCR primer sequence
Primer Sequence (5’-3’) Location Annealing temperature (°C) Product
size (bp)
Reference
IntF GGCATCCAAGCAGCAAGC 5’-CS of class 1 integrons 58 varied [17]
IntB AAGCAGACTTGACCTGAT 3’-CS of class 1 integrons
IntI2L GTAGCAAACGAGTGACGAAATG intI2 58 789 [17]
IntI2R CACGGATATGCGACAAAAAGGT
IntI2CaF GATAAAAACAGCCTGACCTCTTC intI2 58 2433 [17]
IntI2CaR CCCACTTGACATCTCATCAATAC 3’ region of class 2 integrons
ST.GYRA1 TGTCCGAGATGGCCTGAAGC DNA gyrase A 55 470 [18]
ST.GYRA12 CGTTGATGACTTCCGTCAG
mphAF AACTGTACGCACTTGC macrolide 2’-phosphotransferase 50 837 [19]
mphAR GGTACTCTTCGTTACC
Multiplex 1
B/O_F GCGGTCCGGAAAGCCAGAAAAC RNAI 60 159 [15]
B/O_R TCTGCGTTCCGCCAAGTTCGA
FIC_F GTGAACTGGCAGATGAGGAAGG repA2 60 262 [15]
FIC_R TTCTCCTCGTCGCCAAACTAGAT
A/C_F GAGAACCAAAGACAAAGACCTGGA repA 60 465 [15]
A/C_R ACGACAAACCTGAATTGCCTCCTT
P_F CTATGGCCCTGCAAACGCGCCAGAAA iterons 60 534 [15]
P_R TCACGCGCCAGGGCGCAGCC
T_F TTGGCCTGTTTGTGCCTAAACCAT repA 60 750 [15]
T_R CGTTGATTACACTTAGCTTTGGAC
Multiplex 2
K/B_F GCGGTCCGGAAAGCCAGAAAAC RNAI 60 160 [15]
K/B_R TCTTTCACGAGCCCGCCAAA
W_F CCTAAGAACAACAAAGCCCCCG repA 60 242 [15]
W_R GGTGCGCGGCATAGAACCGT
FIIA_F CTGTCGTAAGCTGATGGC repA 60 270 [15]
FIIA_R CTCTGCCACAAACTTCAGC
FIA_F CCATGCTGGTTCTAGAGAAGGTG iterons 60 462 [15]
FIA_R GTATATCCTTACTGGCTTCCGCAG
FIB_F GGAGTTCTGACACACGATTTTCTG repA 60 702 [15]
FIB_R CTCCCGTCGCTTCAGGGCATT
Y_F AATTCAAACAACACTGTGCAGCCTG repA 60 765 [15]
Y_R GCGAGAATGGACGATTACAAAACTTT
Multiplex 3
I1_F CGAAAGCCGGACGGCAGAA RNAI 60 139 [15]
I1_R TCGTCGTTCCGCCAAGTTCGT
Frep_F TGATCGTTTAAGGAATTTTG RNAI/repA 60 270 [15]
Frep_R GAAGATCAGTCACACCATCC
X_F AACCTTAGAGGCTATTTAAGTTGCTGAT ori γ 60 376 [15]
X_R TGAGAGTCAATTTTTATCTCATGTTTTAGC
HI1_F GGAGCGATGGATTACTTCAGTAC parA-parB 60 471 [15]
HI1_R TGCCGTTTCACCTCGTGAGTA
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Table 1 PCR primer sequence (Continued)
N_F GTCTAACGAGCTTACCGAAG repA 60 559 [15]
N_R GTTTCAACTCTGCCAAGTTC
HI2_F TTTCTCCTGAGTCACCTGTTAACAC iterons 60 644 [15]
HI2_R GGCTCACTACCGTTGTCATCCT
L/M_F GGATGAAAACTATCAGCATCTGAAG repA, B, C 60 785 [15]
L/M_R CTGCAGGGGCGATTCTTTAGG
oricolE_F GTTCGTGCATACAGTCCA ColE plasmids 60 187 [16]
oricolE_R GGCGAAACCCGACAGGAC
IncR_F TCGCTTCATTCCTGCTTCAGC IncR plasmids 60 251 [16]
IncR_R GTGTGCTGTGGTTATGCCTCA
IncU_F TCACGACACAAGCGCAAGGG IncU plasmids 60 843 [16]
IncU_R TCATGGTACATCTGGGCGC
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by E-test confirming the resistance described by disk
diffusion assay. All 29 isolates were susceptible to
AZM by disk diffusion assay. The MIC range of AZM by
E-test was 3.0-4.0 μg/ml corresponding to intermediate
susceptibility to AZM (Table 2).PFGE patterns and plasmid patterns analysis
At 80% similarity, the PFGE patterns of all 38 isolates
clustered into 4 groups (Figure 2). Groups 1, 3 and 4
included S. sonnei from Nepal and Thailand. Group 2
consisted of the 29 S. sonnei isolates from Bhutan and
1 isolate from Nepal. S. sonnei isolates from Bhutan were
closely related within the subgroup with 97-100% similarity.
All 30 isolates in group 2 had a pattern of resistance to NA,
CIP, SXT, S and TE (Figure 2).Figure 1 Epidemic curve of S. sonnei isolates in Thimphu, Bhutan fromS. sonnei from Bhutan contained various plasmids with
sizes ranging from 0.35 Kb to 98 Kb. Nine isolates from
Bhutan contained larger plasmids sized from 32 Kb to
98 Kb similar to 1 isolate from Nepal and 4 isolates from
Thailand. Most isolates from all three sites contained
variable plasmids sized from 0.35 Kb to 25 Kb. At 62%
similarity, dendrogram of the plasmid DNA patterns of
S. sonnei was classified into 4 groups. Group 2 consisted
of the 29 S. sonnei isolates from Bhutan and 1 isolate from
Nepal. Groups 1, 3 and 4 included S. sonnei isolates
from Thailand and Nepal with variable antimicrobial
susceptibility patterns [see Additional file 1].Replicon typing
S. sonnei isolates were classified for plasmid incompatibility
by PCR-based replicon typing (PBRT) with 21 primer pairsMarch 2011 to February 2013.







MIC (μg/ml) Integrons DNA Gyrase A mutation Replicon
plasmidAZM NA CIP Ser83 Asp87
Bhutan 19 S, SXT, TE, NA, CIP 3.0-4.0 >256 3.0-4.0 Class 2 Ser83Leu Asp87Gly ColE
Bhutan 9 S, SXT, TE, NA, CIP 3.0-4.0 >256 3.0-4.0 Class 2 Ser83Leu Asp87Gly B/O, ColE
Bhutan 1 S, SXT, TE, NA, CIP 4.0 >256 3.0 Class 2 Ser83Leu Asp87Gly I1, ColE
Nepal 1 S, SXT, TE, NA, CIP 4.0 >256 4.0 Class 2 Ser83Leu Asp87Gly ColE
Nepal 2 S, SXT, TE, NA 3.0-4.0 >256 0.190-0.125 Class 2 Ser83Leu Neg ColE
Nepal 1 S 3.0 3.0 0.008 Neg Neg Neg ColE
Thailand 1 S, SXT, TE, NA, AM 3.0 >256 0.190 Neg Ser83Leu Neg B/O, ColE
Thailand 1 S, SXT, TE, AM 3.0 3.0 0.004 Neg Neg Neg I1, ColE
Thailand 2 S, SXT, TE, NA, AM 3.0-4.0 128 0.004 Class 2 Neg Asp87Tyr I1, ColE
Thailand 1 S, SXT, TE, NA, 4.0 >256 0.004 Class 2 Ser83Leu Neg ColE
AZM, azithromycin; NA, nalidixic acid; CIP, ciprofloxacin; AM, ampicillin; SXT, trimethoprim-sulfamethoxazole; CRO, ceftriaxone; S, streptomycin; TE, tetracycline;
Ser, Serine; Leu, Leucine; Asp, Aspartic acid; Gly, Glycine; Tyr, Tyrosine; Neg, negative result.
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X, HI1, N, HI2, L/M, ColE, IncR and IncU plasmid. All 38
isolates from Bhutan, Nepal, and Thailand carried the ColE
plasmid. Nine isolates from Bhutan and one isolate
from Thailand carried B/O plasmid. One isolate from
Bhutan and three isolates from Thailand carried the
I1 plasmid (Table 2).
PCR and sequencing analysis
The gyrA genes of the 38 S. sonnei isolates from Bhutan,
Nepal and Thailand were amplified. The sequence analysis
of the 470 bp amplified products from 29 S. sonnei isolates
from Bhutan and one isolate from Nepal revealed the
presence of two point mutations in the GyrA subunit
(Ser83Leu and Asp87Gly) (Table 2). However, no
amplified products were observed for the mphA gene
in all 38 S. sonnei isolates compared to an azithromycin
resistant Enteroaggregative E. coli control.
All 38 S. sonnei isolates had amplified products of class
1 integrons of approximately 700 bp. By DNA sequencing,
the amplified products of 5 selected S. sonnei isolates from
Bhutan showed no homologies to published gene cassettes
of class 1 integrons but had 99% identity of conserved
hypothetical protein S. sonnei Ss046 in the NCBI database.
Thus, S. sonnei in Bhutan did not contain resistance genes
in class 1 integrons. The class 2 integrons of 38 S. sonnei
isolates were also amplified. The amplified products of 29
isolates from Bhutan and 3 isolates from Nepal were of
similar size (2.4 Kb) but differed from the class 2 integrons
in the 3 Thailand isolates (~3-4 Kb). The DNA sequence
alignment of class 2 integrons from 5 selected S. sonnei
isolates from Bhutan had homology to dihydrofolate
reductase (dfrA1), streptothricin acetyltransferase (sat1) and
aminiglycoside adenyltransferase (aadA1) associated with
resistance to trimethoprim, streptothricin and streptomycin/
spectinomycin, respectively. Moreover, RFLP of amplifiedproducts of the class 2 integrons in all 38 isolates
with XbaI, yielded the same DNA restricted-fragments of
approximately 1,600 bp and 800 bp in 29 S. sonnei
isolates from Bhutan and 1 isolate from Nepal. The
other Nepal and Thailand isolates had uncut DNA or
undetectable bands.
Discussion
Over the last few years, MDR patterns in Shigella spp.
have been reported in many countries [20]. In this study,
all S. sonnei isolates from children in Thimphu, Bhutan in
June and July, 2011 were resistant to multiple drugs like
ciprofloxacin, nalidixic acid, trimethoprim-sulfamethoxazole,
streptomycin and tetracycline. The MDR patterns of the
S. sonnei from Bhutan differed from neighboring countries.
In India, antimicrobial resistance in S. sonnei is more
common than in other enteric bacteria with resistant to
azithromycin, ciprofloxacin, furazolidone, nalidixic acid,
norfloxacin, ofloxacin, trimethoprim-sulfamethoxazole,
tetracycline [21]. In Bangladesh, most of S. sonnei iso-
lates were resistant to nalidixic acid, sulfamethoxazole-
trimethoprim, ampicillin, streptomycin and tetracycline
[22]. In China, the antimicrobial resistance profiles
of S. sonnei were nalidixic acid, piperacilline and
ciprofloxacin [23]. In Nepal, S. sonnei isolates were resist-
ant to azithromycin, ciprofloxacin, ceftriaxone, ampicillin,
nalidixic acid and trimethoprim-sulfamethoxazole [24].
Shigellae usually harbor various plasmids, such as those
required for bacterial invasion into the host intestinal
epithelial cells and antibiotic resistance, which may range
in number from two to as many as ten in one strain
[25]. The PFGE and plasmid patterns of S. sonnei
from Thimphu, Bhutan suggested clonality. S. sonnei
in Thimphu, Bhutan carried the typical number of variable
plasmid sizes from 0.35 Kb to 98 Kb. These S. sonnei also
contained the typical number of plasmids from seven to
Figure 2 Dendrogram obtained by cluster analysis of the PFGE patterns of S. sonnei from Bhutan, Nepal and Thailand combined with
antibiotic susceptibility. AZM, azithromycin; NA, nalidixic acid; CIP, ciprofloxacin; AM, ampicillin; SXT, trimethoprim-sulfamethoxazole; CRO,
ceftriaxone; S, Streptomycin; TE, tetracycline; S, susceptible; R, resistant; ND, not determined.
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plasmids in homogeneous groups on the basis of their
phylogenetic relatedness is helpful to analyze their
distribution in nature and their relationship to host
cells and to discover their evolutionary origins [26].
Classification of plasmids into incompatibility groups
is desirable because specific plasmid types have been
associated with virulence and/or antimicrobial resistance
[15]. The plasmid replicon typing results showed that all
S. sonnei isolates from Thimphu, Bhutan carried ColE
plasmid as the same as control isolates from Nepal and
Thailand. ColE plasmid which contains genes that code
for colicin protein (bacteriocin protein) that can kill other
bacteria and can replicate in the absence of de novoprotein synthesis [26,27]. Furthermore, ColE plasmids
co-resided with B/O or I1 in several S. sonnei isolates.
The simultaneous presence of the ColE plasmid with
additional plasmids belonging to the I1, B/O or A/C
groups within the same parental strain suggested that
the latter plasmids can participate in the mobilization
of the ColE plasmids. B/O and I1 plasmid are plasmid
incompatibility (Inc) groups capable of carrying transfer,
MDR, and virulence functions [28].
Previous studies reported on the frequent incidence
of class 2 integrons in Shigella isolates worldwide. DNA
sequencing of the class 2 integrons in this study showed
homologies with class 2 integrons but no homologies to
published gene cassettes of class 1 integrons. In this study,
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cassettes (2,433 bp) in transposon Tn7 corresponding to
previous results. S. sonnei isolates from Korea carried class
2 integrons (2,224 bp) that consist of Tn7 with dfrA1, sat1
and aadA1 [29]. In Japan, two types of class 2 integrons in
S. sonnei isolates were previously identified. One was the
classical type (2,158 bp) with dfrA1, sat1 and aadA1. The
other type was shorter (1,313 bp) and carried only two
gene cassettes with dfrA1 and sat1 [20]. In China, a
3,361 bp DNA fragment was found in S. sonnei with gene
cassette arrays in this class 2 integrons of dfrA1, sat1,
aadA1 and orfX [17].
Nalidixic acid resistance among enteric bacteria is
related to the presence of a single amino-acid substitution
at either position 83 or position 87 of GyrA, while
resistance to ciprofloxacin is related to the presence
of at least one additional substitution in GyrA [30]. In this
study, S. sonnei in Thimphu, Bhutan presented two
mutations at position 83 (Serine to Leucine) and position
87 (Aspartic acid to Glycine) related to NA and CIP
resistance. These two mutations conferred extremely
high resistance to NA in S. sonnei in Bhutan that has
been reported previously from S. sonnei isolates in
Japan [31]. The expression of mphA gene is related to
the decrease of AZM susceptibility [19]. In the USA,
isolates with a susceptibility at 8 mg/L lacked mphA gene
but isolates with higher MICs (>64 mg/L) to AZM
reportedly contained a plasmid-encoded mphA gene [19].
In this study, MIC range of AZM was 3.0-4.0 μg/ml and
PCR results showed that mphA gene was not present.Conclusions
This study described the recent antimicrobial resistance
among S. sonnei strains isolated from Thimphu, Bhutan
in June and July, 2011 and molecular characterization of
these S. sonnei. Plasmid patterns, PFGE and uniform
MDR suggest that these 29 S. sonnei isolates are closely
related. All S. sonnei isolates carried common ColE
plasmid that co-resided with B/O or I1 plasmid in
many isolates. Further study and comparison with other
isolates from the region may provide information on the
development and continued spread of antibiotic resistance
in S. sonnei.Additional file
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